Clindamycin and Benzoyl Peroxide (Page 3 of 3)

DOSAGE AND ADMINISTRATION

Clindamycin and Benzoyl Peroxide Gel, 1%/5% should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is gently washed, rinsed with warm water and patted dry.

HOW SUPPLIED AND COMPOUNDING INSTRUCTIONS

Size

(Net Weight)

NDC 0781-

Benzoyl Peroxide Gel

Clindamycin

Phosphate Solution (In plastic bottle)

25 grams

7263-68

20 grams

5 grams

35 grams (pump)

7275-43

28 grams

7 grams

50 grams

7287-50

40 grams

10 grams

50 grams (pump)

7291-46

40 grams

10 grams

Prior to dispensing, add the solution in the bottle to the gel and stir until homogenous in appearance (1 to 1½ minutes). For the 35 and 50 gram pumps only, reassemble jar with pump dispenser.

Clindamycin and Benzoyl Peroxide Gel, 1%/5% (as reconstituted) can be stored at room temperature up to 25°C (77°F) for 3 months. Place a 3 month expiration date on the label immediately following mixing.

Store at room temperature up to 25°C (77°F) [See USP].

Do not freeze. Keep tightly closed. Keep out of the reach of children.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Prescribing Information as of July 2017.

Rx Only

Manufactured by
TOLMAR Inc.
Fort Collins, CO 80526 for
Sandoz Inc. Princeton, NJ 08540

44849 Rev. 3 07/17

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

50g Jar
(click image for full-size original)

50g Jar

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

50g Pump
(click image for full-size original)

50g Pump

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

25g Jar
(click image for full-size original)

25g Jar

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

35g Pump
(click image for full-size original)

CLINDAMYCIN AND BENZOYL PEROXIDE clindamycin and benzoyl peroxide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-7263
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7263-68 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE 5 g
Part 2 1 JAR 20 g
Part 1 of 2
CLINDAMYCIN PHOSPHATE clindamycin phosphate gel
Product Information
Item Code (Source) NDC:0781-6514
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN) CLINDAMYCIN 10 mg in 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-6514-39 5 g in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Part 2 of 2
BENZOYL PEROXIDE benzoyl peroxide gel
Product Information
Item Code (Source) NDC:0781-7262
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOYL PEROXIDE (BENZOYL PEROXIDE) BENZOYL PEROXIDE 50 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
CARBOMER HOMOPOLYMER TYPE C
LIMONENE, (+)-
DOCUSATE SODIUM
PHOSPHORIC ACID
PROPYLENE GLYCOL
WATER
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7262-22 20 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
CLINDAMYCIN AND BENZOYL PEROXIDE clindamycin and benzoyl peroxide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-7275
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7275-43 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE 7 g
Part 2 1 BOTTLE, PUMP 28 g
Part 1 of 2
CLINDAMYCIN PHOSPHATE clindamycin phosphate gel
Product Information
Item Code (Source) NDC:0781-6525
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN) CLINDAMYCIN 10 mg in 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-6525-17 7 g in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Part 2 of 2
BENZOYL PEROXIDE benzoyl peroxide gel
Product Information
Item Code (Source) NDC:0781-7274
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOYL PEROXIDE (BENZOYL PEROXIDE) BENZOYL PEROXIDE 50 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
CARBOMER HOMOPOLYMER TYPE C
LIMONENE, (+)-
DOCUSATE SODIUM
PHOSPHORIC ACID
PROPYLENE GLYCOL
WATER
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7274-28 20 g in 1 BOTTLE, PUMP None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
CLINDAMYCIN AND BENZOYL PEROXIDE clindamycin and benzoyl peroxide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-7291
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7291-46 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE 10 g
Part 2 1 JAR 40 g
Part 1 of 2
CLINDAMYCIN PHOSPHATE clindamycin phosphate gel
Product Information
Item Code (Source) NDC:0781-6536
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN) CLINDAMYCIN 10 mg in 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-6536-21 10 g in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Part 2 of 2
BENZOYL PEROXIDE benzoyl peroxide gel
Product Information
Item Code (Source) NDC:0781-7290
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOYL PEROXIDE (BENZOYL PEROXIDE) BENZOYL PEROXIDE 50 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
CARBOMER HOMOPOLYMER TYPE C
LIMONENE, (+)-
DOCUSATE SODIUM
PHOSPHORIC ACID
PROPYLENE GLYCOL
WATER
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7290-48 40 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
CLINDAMYCIN AND BENZOYL PEROXIDE clindamycin and benzoyl peroxide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-7287
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7287-50 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE 10 g
Part 2 1 BOTTLE, PUMP 40 g
Part 1 of 2
CLINDAMYCIN PHOSPHATE clindamycin phosphate gel
Product Information
Item Code (Source) NDC:0781-6536
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN) CLINDAMYCIN 10 mg in 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-6536-21 10 g in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Part 2 of 2
BENZOYL PEROXIDE benzoyl peroxide gel
Product Information
Item Code (Source) NDC:0781-7286
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOYL PEROXIDE (BENZOYL PEROXIDE) BENZOYL PEROXIDE 50 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
CARBOMER HOMOPOLYMER TYPE C
LIMONENE, (+)-
DOCUSATE SODIUM
PHOSPHORIC ACID
PROPYLENE GLYCOL
WATER
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0781-7286-44 40 g in 1 BOTTLE, PUMP None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204087 08/15/2017
Labeler — Sandoz Inc. (005387188)
Establishment
Name Address ID/FEI Operations
TOLMAR Inc. 791156578 ANALYSIS (0781-7287), ANALYSIS (0781-7262), ANALYSIS (0781-6525), ANALYSIS (0781-6525), ANALYSIS (0781-7274), ANALYSIS (0781-7274), ANALYSIS (0781-7290), ANALYSIS (0781-6536), ANALYSIS (0781-6536), ANALYSIS (0781-7286), ANALYSIS (0781-7275), ANALYSIS (0781-7263), ANALYSIS (0781-7291), ANALYSIS (0781-6514), LABEL (0781-7287), LABEL (0781-7262), LABEL (0781-6525), LABEL (0781-6525), LABEL (0781-7274), LABEL (0781-7274), LABEL (0781-7290), LABEL (0781-6536), LABEL (0781-6536), LABEL (0781-7286), LABEL (0781-7275), LABEL (0781-7263), LABEL (0781-7291), LABEL (0781-6514), MANUFACTURE (0781-7262), MANUFACTURE (0781-6525), MANUFACTURE (0781-6525), MANUFACTURE (0781-7274), MANUFACTURE (0781-7274), MANUFACTURE (0781-7290), MANUFACTURE (0781-6536), MANUFACTURE (0781-6536), MANUFACTURE (0781-7286), MANUFACTURE (0781-7287), MANUFACTURE (0781-7275), MANUFACTURE (0781-7263), MANUFACTURE (0781-7291), MANUFACTURE (0781-6514), PACK (0781-7262), PACK (0781-6525), PACK (0781-6525), PACK (0781-7274), PACK (0781-7274), PACK (0781-7290), PACK (0781-6536), PACK (0781-6536), PACK (0781-7286), PACK (0781-7287), PACK (0781-7275), PACK (0781-7263), PACK (0781-7291), PACK (0781-6514)

Revised: 12/2020 Sandoz Inc.

Page 3 of 3 1 2 3

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.